$12.75M Securities Settlement Against Cancer Drug Maker Gains Initial Approval

Mealey's (January 14, 2022, 8:04 AM EST) -- SAN DIEGO — A federal judge in California on Jan. 11 granted preliminary approval of a $12.75 million settlement in a class action against a pharmaceutical company and certain of its...
To view the full article, register now.